Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Canadian Cancer Trials Group
ClinicalTrials.gov Identifier:
NCT01396408
First received: July 14, 2011
Last updated: March 27, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)